Flash Info Biotech

SOUTH SAN FRANCISCO, Calif. & INGELHEIM, Germany — May 7, 2009 – Exelixis, Inc. (Nasdaq: EXEL) and Boehringer Ingelheim, a global pharmaceutical group of companies, headquartered in Germany, announced today that they have established an exclusive, worldwide collaboration with the aim to discover, develop and commercialize autoimmune disease therapies. The collaboration is focused on the [...]

MONTPELLIER – Les 8 centres hospitaliers et centres de lutte contre le cancer des 4 régions du « grand sud-ouest » finalisent leur tumorothèque dont le catalogue commun devrait être consultable dans dix jours, ont annoncé mercredi les responsables du Cancéropôle Grand sud ouest (GSO) à Montpellier. Une tumorothèque est une collection de tissus tumoraux complétés d’informations [...]

MONTPELLIER – Les 8 centres hospitaliers et centres de lutte contre le cancer des 4 régions du « grand sud-ouest » finalisent leur tumorothèque dont le catalogue commun devrait être consultable dans dix jours, ont annoncé mercredi les responsables du Cancéropôle Grand sud ouest (GSO) à Montpellier. Une tumorothèque est une collection de tissus tumoraux complétés d’informations [...]

By Alan MozesHealthDay ReporterFriday, October 3, 2008; 12:00 AM FRIDAY, Oct. 3 (HealthDay News) — A simple urine test could one day be an effective way to screen for breast cancer, a new study suggests. The notion of a so-called « dipstick » test envisions a high-tech sifting through just a few drops of urine in the [...]

September 24, 2008 09:00 AM Eastern Daylight Time Nanobiotix et BiotechCorp annoncent l’objectif initial de leur collaboration : le système de diagnostic « point-of-care » et le système d’administration de médicaments destinés aux maladies tropicales, telles que le paludisme PARIS–(BUSINESS WIRE)–Nanobiotix, une société émergente spécialisée dans la nanomédecine et axée sur les traitements anticancéreux, a [...]

LONDON & PHILADELPHIA & CARLSBAD, Calif.–(BUSINESS WIRE)–GlaxoSmithKline (GSK) and Regulus Therapeutics LLC (Regulus) today announced a worldwide strategic alliance to discover, develop and market novel microRNA-targeted therapeutics to treat inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease. Regulus is a joint venture between Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and Isis Pharmaceuticals, Inc. (Nasdaq: [...]

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Cell Genesys, Inc. (Nasdaq:CEGE) announced today that immunological data from the ongoing Phase 1 clinical trial of GVAX immunotherapy for prostate cancer in combination with ipilimumab (MDX-010) suggest an association between an increase in T-cell immunity and anti-tumor activity as measured by a decrease in prostate-specific antigen (PSA) serum levels. These [...]

BOTHELL, Wash. & SAN DIEGO–(BUSINESS WIRE)–Seattle Genetics, Inc. (NASDAQ:SGEN) today announced data from multiple poster presentations at the 2008 Annual Meeting of the American Association for Cancer Research (AACR) highlighting preclinical findings with its proprietary antibody-drug conjugate (ADC) technology. Preclinical data were also presented on SGN-33, a humanized antibody that is in clinical trials for [...]

Early Data Presented from Investigational Molecules that Target Apoptosis and Growth Regulation Pathways Abstract Numbers: 3162, 1326, 3999, 2804, 4001, 3994 SAN DIEGO–(BUSINESS WIRE)–Amgen (NASDAQ:AMGN) today announced data generated by the company’s robust oncology research and development programs in the areas of apoptosis (programmed cell death) and cell growth regulation. The data, presented at the [...]

EUGENE, Ore.–(BUSINESS WIRE)–The biotechnology company MitoSciences Inc. and the University of Oregon today announced the completion of an exclusive commercial license for a suite of biotechnology innovations. The agreement centers on a portfolio of monoclonal antibodies — specialized proteins that bind to specific biological molecules — that were developed at the UO. Researchers and drug [...]